NextCure, Inc. – NASDAQ:NXTC
Founder-led company
NextCure stock price today
$5.09
+4.27
+520.73%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
NextCure stock price monthly change
-50.30%
month
NextCure stock price quarterly change
-50.30%
quarter
NextCure stock price yearly change
-28.07%
year
NextCure key metrics
Market Cap | 27.13M |
Enterprise value | 22.38M |
P/E | -0.55 |
EV/Sales | N/A |
EV/EBITDA | -0.31 |
Price/Sales | N/A |
Price/Book | 0.25 |
PEG ratio | 0.07 |
EPS | -2.28 |
Revenue | N/A |
EBITDA | -62.66M |
Income | -63.73M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNextCure stock price history
NextCure stock forecast
NextCure financial statements
| Jun 2023 | 0 | -17.85M | |
|---|---|---|---|
| Sep 2023 | 0 | -14.30M | |
| Dec 2023 | 6.28M | -14.46M | -230.22% |
| Mar 2024 | 0 | -17.10M |
| Mar 2024 | 0 | -17.10M | |
|---|---|---|---|
| Sep 2025 | 0 | -11.72M | |
| Oct 2025 | 0 | -11.57M | |
| Dec 2025 | 0 | -11.99M |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 153380000 | 14.95M | 9.75% |
|---|---|---|---|
| Sep 2023 | 139939000 | 13.48M | 9.64% |
| Dec 2023 | 129418000 | 14.99M | 11.59% |
| Mar 2024 | 115159000 | 16.11M | 13.99% |
| Jun 2023 | -14.74M | 6.71M | 83K |
|---|---|---|---|
| Sep 2023 | -12.77M | 10.27M | 0 |
| Dec 2023 | -10.67M | 4.16M | 71K |
| Mar 2024 | -12.60M | 17.88M | 1K |
NextCure alternative data
| Aug 2023 | 99 |
|---|---|
| Sep 2023 | 99 |
| Oct 2023 | 99 |
| Nov 2023 | 99 |
| Dec 2023 | 99 |
| Jan 2024 | 99 |
| Feb 2024 | 99 |
| Mar 2024 | 82 |
| Apr 2024 | 82 |
| May 2024 | 82 |
| Jun 2024 | 82 |
| Jul 2024 | 82 |
NextCure other data
22.08%
-26.17%
of NXTC is owned by hedge funds
26
-18
6.12M
-7.26M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2019 | 1325000 | 0 |
| Nov 2019 | 150000 | 0 |
| Patent |
|---|
Application Filling date: 3 Aug 2017 Issue date: 25 Nov 2021 |
Application Filling date: 23 Jan 2019 Issue date: 4 Feb 2021 |
Application Filling date: 1 Mar 2019 Issue date: 7 Jan 2021 |
| Insider | Compensation |
|---|---|
| Mr. Michael S. Richman (1961) Co-Founder, Chief Executive Officer, Pres & Director | $643,940 |
Dr. Solomon Langermann (1959) Chief Scientific Officer | $453,410 |
-
What's the price of NextCure stock today?
One share of NextCure stock can currently be purchased for approximately $5.09.
-
When is NextCure's next earnings date?
Unfortunately, NextCure's (NXTC) next earnings date is currently unknown.
-
Does NextCure pay dividends?
No, NextCure does not pay dividends.
-
How much money does NextCure make?
NextCure has a market capitalization of 27.13M.
-
What is NextCure's stock symbol?
NextCure, Inc. is traded on the NASDAQ under the ticker symbol "NXTC".
-
What is NextCure's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NextCure?
Shares of NextCure can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NextCure's key executives?
NextCure's management team includes the following people:
- Mr. Michael S. Richman Co-Founder, Chief Executive Officer, Pres & Director(age: 64, pay: $643,940)
- Dr. Solomon Langermann Chief Scientific Officer(age: 66, pay: $453,410)
-
Is NextCure founder-led company?
Yes, NextCure is a company led by its founder Mr. Michael S. Richman.
-
How many employees does NextCure have?
As Jul 2024, NextCure employs 82 workers.
-
When NextCure went public?
NextCure, Inc. is publicly traded company for more then 6 years since IPO on 9 May 2019.
-
What is NextCure's official website?
The official website for NextCure is nextcure.com.
-
Where are NextCure's headquarters?
NextCure is headquartered at 9000 Virginia Manor Road, Beltsville, MD.
-
How can i contact NextCure?
NextCure's mailing address is 9000 Virginia Manor Road, Beltsville, MD and company can be reached via phone at +240 3994900.
NextCure company profile:
NextCure, Inc.
nextcure.comExchange:
NASDAQ
Full time employees:
82
Industry:
Biotechnology
Sector:
Healthcare
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
9000 Virginia Manor Road
Beltsville, MD 20705
Beltsville, MD 20705
CIK: 0001661059
ISIN: US65343E1082
CUSIP: 65343E108
